GSK Plc (GLAXF)
27.00
-0.04
(-0.15%)
USD |
OTCM |
Mar 13, 16:00
GSK Market Cap : 108.17B for March 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Silence Therapeutics Plc | 283.40M |
| Adaptimmune Therapeutics Plc | 0.5831M |
| Biodexa Pharmaceuticals Plc | 0.697M |
| Oxford Biomedica Plc | 982.08M |
| NuCana Plc | 7.949M |
Market Cap Related Metrics
| PE Ratio | 14.74 |
| PS Ratio | 2.573 |
| PEG Ratio | 0.1121 |
| Price to Book Value | 4.910 |
| Price to Free Cash Flow | 19.32 |
| Price | 27.00 |
| Earnings Yield | 6.78% |
| PEGY Ratio | 0.1094 |
| Operating PE Ratio | 11.40 |
| Normalized PE Ratio | 13.65 |